BLINATUMOMAB BRIDGING THERAPY FOR EFFECTIVE MANAGEMENT OF MRD IN PRO-B ALL WITH CNS INVOLVEMENT: A CASE REPORT OF POST TRANSPLANT PATIENT AT 23 MONTHS AFTER ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION Ceren Dehri Bah¿i; Birol Güvenç;

Prognostic factors and impact of CMV reactivation on acute myeloid leukemia patients after HLA-matched myeloablative allogeneic stem cell transplantation in a high CMV prevalence country Chantiya Chanswangphuwana; Kitsada Wudhikarn; Phandee Watanaboonyongcharoen; Patsita Kansuwan; Autcharaporn Sukperm; Udomsak Bunworasate;

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients Diego V. Clé; Alexandre V. Hirayama; Alvaro J. Alencar; Luciano J. Costa; João V.P. Feliciano; Ederson R. Mattos; Ana C. Cordeiro; Marco Aurélio Salvino; George M. Navarro Barros; Marcos de Lima; Phillip Scheinberg; Renato L. Guerino-Cunha;